GRHL2 has been implicated in metastasis in breast cancer (Werner et al., 2013, Xiang et al., 2012), and we hypothesize that its influence on cell migration and metastatic potential is attributed to its ability to tether MLL3 at chromatin and mediate enhancer activity. Here, KMT2C is linked to breast carcinoma.